Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis

  1. Santisteban, M.
  2. Solans, B.P.
  3. Hato, L.
  4. Urrizola, A.
  5. Mejías, L.D.
  6. Salgado, E.
  7. Sánchez-Bayona, R.
  8. Toledo, E.
  9. Rodríguez-Spiteri, N.
  10. Olartecoechea, B.
  11. Idoate, M.A.
  12. López-Díaz de Cerio, A.
  13. Inogés, S.
Revista:
Therapeutic Advances in Medical Oncology

ISSN: 1758-8359 1758-8340

Ano de publicación: 2021

Volume: 13

Tipo: Artigo

DOI: 10.1177/17588359211064653 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable